The phase 2 semaglutide NASH trial (published in NEJM, 2021) demonstrated NASH resolution in a significant proportion of patients, though fibrosis improvement was modest
There actually is a very slight mixing of hexane and water molecules
Possible side effects associated with the generic and GLP-1 medications prescribed, according to research, include nausea, diarrhea, bloat, low blood sugar, and constipation
The doses of these medications are much higher than what the gut makes naturally
The six IGFBPs serve as carrier proteins that bind approximately 98% of all circulating native IGF-1, with binding affinity equal to or greater than that of the IGF-1 receptor itself meaning the vast majority of native IGF-1 is sequestered before reaching its receptor